Home › Funds › ACT CAPITAL MANAGEMENT, LLC › VIR

ACT CAPITAL MANAGEMENT, LLC position in VIR

VIR BIOTECHNOLOGY INC · Health Care

ACT CAPITAL MANAGEMENT, LLC reported holding 64,300 shares of VIR (VIR BIOTECHNOLOGY INC) in its Q2 2026 13F filing — a position valued at US$655K, representing 0.43% of its reported portfolio and ranking #34 among its reported holdings. ACT CAPITAL MANAGEMENT, LLC has disclosed VIR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)64.30K sh
Reported value held$655.22K
Portfolio Weight0.43%
First reportedQ1 2026
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How ACT CAPITAL MANAGEMENT, LLC's VIR position evolved

ACT CAPITAL MANAGEMENT, LLC first disclosed a stake in VIR in Q1 2026 at 64,300 shares (US$576K). The position peaked in Q2 2026 at 64,300 shares, worth US$655K. Across 2 filings, ACT CAPITAL MANAGEMENT, LLC held the position steady without any share-count change. The most recent filing (Q2 2026) shows 64,300 shares valued at US$655K.

Quarter by quarter

QuarterSharesValueChange
Q1 2026 64.30K $576.13K New
Q2 2026 64.30K $655.22K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VIR and 13F data

VIR (VIR BIOTECHNOLOGY INC) is a Health Care company. 50 other funds we track also report a position in VIR — the largest reported positions include ARCH Venture Management, LLC (US$129.4M), SB INVESTMENT ADVISERS (UK) LTD (US$111.6M), GSK plc (US$87.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VIR

All VIR fund holders →

FAQ

How long has ACT CAPITAL MANAGEMENT, LLC held VIR?

ACT CAPITAL MANAGEMENT, LLC has disclosed VIR holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is ACT CAPITAL MANAGEMENT, LLC's current position in VIR?

As of Q2 2026, ACT CAPITAL MANAGEMENT, LLC holds 64.30K shares of VIR (VIR BIOTECHNOLOGY INC), valued at $655.22K, representing 0.43% of its reported portfolio and ranking #34.

Has ACT CAPITAL MANAGEMENT, LLC been buying or selling VIR?

In the latest 13F filing (Q2 2026), ACT CAPITAL MANAGEMENT, LLC held unchanged its position in VIR. The position peaked in Q2 2026 at 64.30K shares.

Which other funds hold VIR?

Other major institutional holders of VIR include ARCH Venture Management, LLC, SB INVESTMENT ADVISERS (UK) LTD, GSK plc, among 50 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.